David H. Willse

Array ( [id] => 6555033 [patent_doc_number] => 20020164358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Anti-cancer vaccine' [patent_app_type] => new [patent_app_number] => 10/046880 [patent_app_country] => US [patent_app_date] => 2002-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6916 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164358.pdf [firstpage_image] =>[orig_patent_app_number] => 10046880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921146 [patent_doc_number] => 20020114812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Methods and compositions for modulating regulation of the cytotoxic lymphocyte response by macrophage migration inhibitory factor' [patent_app_type] => new [patent_app_number] => 10/043322 [patent_app_country] => US [patent_app_date] => 2002-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10327 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20020114812.pdf [firstpage_image] =>[orig_patent_app_number] => 10043322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5865446 [patent_doc_number] => 20060099576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Method for diagnosing a pre-neoplastic or neoplastic lesion in transitional epithelial cells' [patent_app_type] => utility [patent_app_number] => 10/014320 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14424 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099576.pdf [firstpage_image] =>[orig_patent_app_number] => 10014320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 745790 [patent_doc_number] => 07026462 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-11 [patent_title] => 'Regulation of angiogenesis with zinc finger proteins' [patent_app_type] => utility [patent_app_number] => 10/006069 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 31 [patent_no_of_words] => 45343 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/026/07026462.pdf [firstpage_image] =>[orig_patent_app_number] => 10006069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1096282 [patent_doc_number] => 06821947 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-23 [patent_title] => 'Endorepellin: methods and compositions for inhibiting angiogenesis' [patent_app_type] => B2 [patent_app_number] => 10/006011 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 17234 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/821/06821947.pdf [firstpage_image] =>[orig_patent_app_number] => 10006011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 732166 [patent_doc_number] => 07037664 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-02 [patent_title] => 'Apoptosis marker antibodies and methods of use' [patent_app_type] => utility [patent_app_number] => 10/011321 [patent_app_country] => US [patent_app_date] => 2001-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18790 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/037/07037664.pdf [firstpage_image] =>[orig_patent_app_number] => 10011321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 806801 [patent_doc_number] => 07420036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-02 [patent_title] => 'Anti-angiogenic polypeptides' [patent_app_type] => utility [patent_app_number] => 10/415012 [patent_app_country] => US [patent_app_date] => 2001-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 19375 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/420/07420036.pdf [firstpage_image] =>[orig_patent_app_number] => 10415012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5968322 [patent_doc_number] => 20020090712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Rab proteins' [patent_app_type] => new [patent_app_number] => 09/988974 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18927 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20020090712.pdf [firstpage_image] =>[orig_patent_app_number] => 09988974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6744655 [patent_doc_number] => 20030021838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'METHOD OF MAKING THERAPEUTIC LIPOSOMAL COMPOSITIONS' [patent_app_type] => new [patent_app_number] => 09/985630 [patent_app_country] => US [patent_app_date] => 2001-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6387 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20030021838.pdf [firstpage_image] =>[orig_patent_app_number] => 09985630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 691467 [patent_doc_number] => 07074909 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'Antibodies' [patent_app_type] => utility [patent_app_number] => 10/016686 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 27 [patent_no_of_words] => 27175 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074909.pdf [firstpage_image] =>[orig_patent_app_number] => 10016686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 379921 [patent_doc_number] => 07309492 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-18 [patent_title] => 'Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of systemic lupus erythematosus' [patent_app_type] => utility [patent_app_number] => 10/003211 [patent_app_country] => US [patent_app_date] => 2001-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 41 [patent_no_of_words] => 18361 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/309/07309492.pdf [firstpage_image] =>[orig_patent_app_number] => 10003211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869447 [patent_doc_number] => 20030082136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Anti-tumor vaccine' [patent_app_type] => new [patent_app_number] => 10/016528 [patent_app_country] => US [patent_app_date] => 2001-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4775 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082136.pdf [firstpage_image] =>[orig_patent_app_number] => 10016528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921139 [patent_doc_number] => 20020114807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumor therapies' [patent_app_type] => new [patent_app_number] => 10/007275 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3417 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20020114807.pdf [firstpage_image] =>[orig_patent_app_number] => 10007275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122046 [patent_doc_number] => 20050013875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Immunopotentiators in thermotherapy for cancer' [patent_app_type] => utility [patent_app_number] => 10/493665 [patent_app_country] => US [patent_app_date] => 2001-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3811 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20050013875.pdf [firstpage_image] =>[orig_patent_app_number] => 10493665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6014941 [patent_doc_number] => 20020102236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Liposomal interferon hybrid compositions' [patent_app_type] => new [patent_app_number] => 10/001755 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1772 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102236.pdf [firstpage_image] =>[orig_patent_app_number] => 10001755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7199829 [patent_doc_number] => 20040086557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Macrimmune V, a composition for treating cancer' [patent_app_type] => new [patent_app_number] => 09/983129 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2499 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086557.pdf [firstpage_image] =>[orig_patent_app_number] => 09983129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6618190 [patent_doc_number] => 20020086007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Angiogenesis-inhibiting peptides and proteins and methods of use' [patent_app_type] => new [patent_app_number] => 09/978531 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9482 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086007.pdf [firstpage_image] =>[orig_patent_app_number] => 09978531 [rel_patent_id] =>[rel_patent_doc_number] =>)